Literature DB >> 15201256

Plasma homocysteine and calcific aortic valve disease.

G M Novaro, H D Aronow, E Mayer-Sabik, B P Griffin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15201256      PMCID： PMC1768317          DOI： 10.1136/hrt.2003.022889

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve.

Authors:  K L Chan; M Ghani; K Woodend; I G Burwash
Journal:  Am J Cardiol       Date:  2001-09-15       Impact factor: 2.778

2.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

Authors:  B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

3.  Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.

Authors:  K S McCully
Journal:  Am J Pathol       Date:  1969-07       Impact factor: 4.307

4.  Hyperhomocysteinemia: an independent risk factor for vascular disease.

Authors:  R Clarke; L Daly; K Robinson; E Naughten; S Cahalane; B Fowler; I Graham
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

5.  Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.

Authors:  C M Otto; J Kuusisto; D D Reichenbach; A M Gown; K D O'Brien
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690
  5 in total
  8 in total

1.  Validation of plasma biomarkers in degenerative calcific aortic stenosis.

Authors:  Giovanni Ferrari; Rachana Sainger; Erik Beckmann; Gianluca Keller; Pey-Jen Yu; Maria Cristina Monti; Aubrey C Galloway; Richard L Weiss; William Vernick; Juan B Grau
Journal:  J Surg Res       Date:  2010-05-06       Impact factor: 2.192

2.  Comparison of transesophageal echocardiographic analysis and circulating biomarker expression profile in calcific aortic valve disease.

Authors:  Rachana Sainger; Juan B Grau; Emanuela Branchetti; Paolo Poggio; Eric Lai; Erblina Koka; William J Vernick; Robert C Gorman; Joseph E Bavaria; Giovanni Ferrari
Journal:  J Heart Valve Dis       Date:  2013-03

3.  Dephosphorylation of circulating human osteopontin correlates with severe valvular calcification in patients with calcific aortic valve disease.

Authors:  Rachana Sainger; Juan B Grau; Paolo Poggio; Emanuela Branchetti; Joseph E Bavaria; Joseph H Gorman; Robert C Gorman; Giovanni Ferrari
Journal:  Biomarkers       Date:  2011-12-23       Impact factor: 2.658

Review 4.  Insights into the use of biomarkers in calcific aortic valve disease.

Authors:  Erik Beckmann; Juan B Grau; Rachana Sainger; Paolo Poggio; Giovanni Ferrari
Journal:  J Heart Valve Dis       Date:  2010-07

5.  Epigenetic regulation of aortic remodeling in hyperhomocysteinemia.

Authors:  Nithya Narayanan; Sathnur Basappa Pushpakumar; Srikanth Givvimani; Sourav Kundu; Naira Metreveli; Dexter James; Adrienne P Bratcher; Suresh C Tyagi
Journal:  FASEB J       Date:  2014-04-16       Impact factor: 5.191

6.  Association between homocysteine levels and calcific aortic valve disease: a systematic review and meta-analysis.

Authors:  Guandi Wu; Jiayi Xian; Xi Yang; Jiaying Li; Jichen Liu; Wenhui Dong; Shuwen Su; Jun Li; Yan Tu; Jian Peng; Dingli Xu; Qingchun Zeng
Journal:  Oncotarget       Date:  2018-01-03

Review 7.  Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.

Authors:  Nikolas Rapp; Pieter Evenepoel; Peter Stenvinkel; Leon Schurgers
Journal:  Toxins (Basel)       Date:  2020-09-29       Impact factor: 4.546

8.  Metabolomics in Severe Aortic Stenosis Reveals Intermediates of Nitric Oxide Synthesis as Most Distinctive Markers.

Authors:  Beau Olivier van Driel; Maike Schuldt; Sila Algül; Evgeni Levin; Ahmet Güclü; Tjeerd Germans; Albert C van Rossum; Jiayi Pei; Magdalena Harakalova; Annette Baas; Judith J M Jans; Jolanda van der Velden
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.